1-Jahres-Chart (nicht börsennotiert)
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 21.03. | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 21.03.2024 | 475 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 21.03.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 21.03.2024ISIN NameCA0324721020 ANACOTT... ► Artikel lesen | |
| 20.03. | Neighbourly Pharmacy Inc.: Neighbourly Announces Successful Closing of Take-Private Transaction with Persistence Capital Partners | 69 | PR Newswire | TORONTO, March 20, 2024 /CNW/ - Neighbourly Pharmacy Inc. ("Neighbourly" or the "Company") (TSX: NBLY), Canada's largest and fastest growing network of independent pharmacies, is pleased to announce... ► Artikel lesen | |
| 20.03. | Neighbourly Pharmacy Inc: Neighbourly closes go-private deal with Persistence | 1 | Stockwatch | ||
| 14.03. | Neighbourly Pharmacy Inc: Neighbourly receives final court OK for buyout | 1 | Stockwatch | ||
| 14.03. | Neighbourly Pharmacy Inc.: Neighbourly Receives Final Court Approval of Plan of Arrangement to be Acquired by Persistence Capital Partners | 94 | PR Newswire | TORONTO, March 13, 2024 /CNW/ - Neighbourly Pharmacy Inc. ("Neighbourly" or the "Company") (TSX: NBLY), Canada's largest and fastest growing network of independent pharmacies, is pleased to announce... ► Artikel lesen | |
| 08.03. | Neighbourly Pharmacy Inc: Neighbourly receives shareholder OK for go-private deal | 1 | Stockwatch | ||
| 08.03. | Neighbourly Pharmacy Inc.: Neighbourly Obtains Shareholder Approval for Going Private Transaction with Persistence Capital Partners | 84 | PR Newswire | TORONTO, March 8, 2024 /CNW/ - Neighbourly Pharmacy Inc. ("Neighbourly" or the "Company") (TSX: NBLY), Canada's largest and fastest growing network of independent pharmacies, announced today that... ► Artikel lesen | |
| 13.02. | Neighbourly Pharmacy Inc: Neighbourly Pharmacy loses $4.54-million in fiscal Q3 | 1 | Stockwatch | ||
| 13.02. | Neighbourly Pharmacy Inc. Non-GAAP EPS of C$0.19, revenue of C$284M | 1 | Seeking Alpha | ||
| 13.02. | Neighbourly Pharmacy Inc.: Neighbourly Announces Strong Third Quarter Results | 43 | PR Newswire | Company delivers strong pharmacy same store sales performance as its retail footprint expands to 294 locations
TORONTO, Feb. 13, 2024 /CNW/ - Neighbourly Pharmacy Inc. ("Neighbourly" or the "Company")... ► Artikel lesen | |
| 12.02. | Neighbourly Pharmacy Announces Filing of Special Meeting Materials and Receipt of Interim Order in Respect of Go-Private Arrangement with Persistence Capital Partners | 1 | CNW | ||
| 12.02. | Neighbourly Pharmacy Inc: Neighbourly to hold holder meeting for Persistence deal | 1 | Stockwatch | ||
| 01.02. | Neighbourly Pharmacy Inc: Neighbourly to release fiscal Q3 results Feb. 13 | 1 | Stockwatch | ||
| 01.02. | Neighbourly Pharmacy Announces Timing of Third Quarter 2024 Earnings Release | 1 | CNW | ||
| 23.01. | Neighbourly Pharmacy Inc: Neighbourly Pharmacy names Dyer people, culture SVP | 1 | Stockwatch | ||
| 23.01. | Neighbourly Pharmacy Appoints Maura Dyer as Senior Vice President, People and Culture | 1 | CNW | ||
| 15.01. | Stocks in Play: Neighbourly Pharmacy Inc. | - | Baystreet.ca | ||
| 15.01. | Neighbourly Pharmacy Inc: Neighbourly to go private with Persistence Capital | 1 | Stockwatch | ||
| 15.01. | Neighbourly Pharmacy Inc.: Neighbourly Enters into Definitive Agreement to go Private with its Controlling Shareholder Persistence Capital Partners | 38 | PR Newswire | Offer of $18.50 in cash plus one contingent value right of $0.61 per share
Board has unanimously agreed to support and recommends that minority shareholders approve the transaction
TORONTO, Jan.... ► Artikel lesen | |
| 18.12.23 | Neighbourly Pharmacy Inc: Neighbourly receives revised proposal from Persistence | 2 | Stockwatch |
Seite:
1 2 Weiter >>
31 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 52,94 | +1,22 % | DZ BANK stuft Siemens Healthineers auf 'Halten' | FRANKFURT (dpa-AFX Analyser) - Die DZ Bank hat den fairen Wert für Siemens Healthineers vor Zahlen von 52 auf 53 Euro angehoben und die Einstufung auf "Halten" belassen. Analyst Sven Kürten erwartet... ► Artikel lesen | |
| FRESENIUS | 27,210 | +0,11 % | Cardiol Therapeutics, Bayer AG, Fresenius Aktie - wer ist der Trendsetter im Gesundheitsmarkt von morgen? | Die Gesundheitsbranche ist ein lukratives Segment für risikobewusste Anleger. Die globale Marktgröße für Gesundheitsdienstleistungen wird voraussichtlich bis 2028 eine jährliche Wachstumsrate (CAGR)... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 37,420 | -0,98 % | Fresenius Medical Care: Was war das denn gestern? | Mit einem Kursanstieg um satte 6,44 Prozent wurde Fresenius Medical Care am Montag klarer Tagessieger im MDAX. Aber was war da los, was trieb die Aktie so stark? Vorab-Ergebnisse zum ersten Quartal... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 100,30 | +1,31 % | JPMORGAN stuft CARL ZEISS MEDITEC AG auf 'Underweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Carl Zeiss Meditec vor Zahlen für das zweite Geschäftsquartal auf "Underweight" mit einem Kursziel von 70 Euro belassen. Seine... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 51,83 | -0,86 % | PROCEPT BioRobotics Announces Preliminary Fourth Quarter Revenue of $43.3 million to $43.6 million | SAN JOSE, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| GERRESHEIMER | 100,50 | +1,31 % | JEFFERIES stuft GERRESHEIMER AG auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat das Kursziel für Gerresheimer von 126 auf 128 Euro angehoben und die Einstufung auf "Buy" belassen. Es werde wohl noch ein Quartal dauern... ► Artikel lesen | |
| PROGYNY | 32,040 | -1,42 % | Progyny, Inc. Announces Details for Its First Quarter 2024 Results Report | ||
| MOBILE-HEALTH NETWORK SOLUTIONS | 23,890 | +0,46 % | APAC Telehealth Leader MNDR Expects Revenue Growth in H12024 vs H12023 | SINGAPORE, April 22, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (Nasdaq: MNDR) ("Mobile-Health" or the "Company"), a pioneering Asia-Pacific ("APAC") telehealth provider, today provided... ► Artikel lesen | |
| NEWGENIVF GROUP | 1,780 | +36,92 % | Pre-market Movers: Tevogen Bio, Freight Technologies, NewGenIvf Group, Snap, U.S. Silica | MOUNTAIN VIEW (dpa-AFX) - The following are some of the stocks making big moves in Friday's pre-market trading (as of 09.15 A.M. ET).In the Green Tevogen Bio Holdings Inc. (TVGN) is up over... ► Artikel lesen | |
| ATRICURE | 23,170 | +2,48 % | AtriCure upgraded at Oppenheimer on valuation | ||
| ADAPTHEALTH | 9,960 | +3,97 % | AdaptHealth Corp. Announces Fourth Quarter and Full-Year 2023 Results and Provides Initial 2024 Outlook | PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including... ► Artikel lesen | |
| LIFEMD | 11,950 | +10,44 % | LifeMD, Inc.: LifeMD to Report First Quarter 2024 Financial Results on May 8 | ||
| BRIGHTSPRING HEALTH SERVICES | 10,580 | +1,63 % | BrightSpring Health Services appoints Timothy Wick to its board of directors | ||
| ECKERT & ZIEGLER | 36,720 | +1,89 % | Eckert & Ziegler: Kurssprung nach Vorab-Zahlen … was ist das wert? | Am Montagnachmittag wartete der Strahlentechnik-Spezialist Eckert & Ziegler mit vorläufigen Ergebnissen zum 1. Quartal auf. Die Aktie machte einen Satz nach oben ... wie lässt sich das charttechnisch... ► Artikel lesen | |
| GOODRX | 7,190 | +1,55 % | GoodRx Reports Fourth Quarter and Full Year 2023 Results | SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("GoodRx" or the "Company"), the leading destination for prescription savings in the U.S., has released its financial... ► Artikel lesen |
Das Unternehmen NEIGHBOURLY PHARMACY INC kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 12,500 Euro und damit 0,00 % im Plus. Die Dividendendrendite beträgt aktuell +0,24 % (berechnet anhand der Ausschüttung von 0,03 Euro in den letzten 12 Monaten).
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
